Suchergebnisse - (Subject:"ritonavir")

PubPharm (98)

41

Pharmacokinetic characterization of three doses of tipranavir boosted with ritonavir on highly active antiretroviral therapy in treatment-experienced HIV-1 patients

enthalten in: HIV clinical trials | 2010

von Goebel, F. | MacGregor, T. | Sabo, J. | +4

42

Study of once-daily versus twice-daily fosamprenavir plus ritonavir administered with abacavir/lamivudine once daily in antiretroviral-naïve HIV-1-infected adult subjects

enthalten in: HIV clinical trials | 2009

von Carosi | Lazzarin | Stellbrink | +9

43

Monotherapy with Lopinavir/Ritonavir as maintenance after HIV-1 viral suppression : results of a 96-week randomized, controlled, open-label, pilot trial (KalMo study)

enthalten in: HIV clinical trials | 2009

von Nunes, E. | Santini de Oliveira, M. | Merçon, M. | +6

44

Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir

enthalten in: HIV clinical trials | 2009

von Rathbun, C. | Liedtke, M. | Blevins, S. | +4

45

Efficacy and safety of an NRTI-sparing dual regimen of raltegravir and ritonavir-boosted protease inhibitor in a triple antiretroviral class-experienced population

enthalten in: HIV clinical trials | 2009

von Allavena, C. | Mounoury, O. | Rodallec, A. | +3

46

Short-term effect of ritonavir-boosted atazanavir in hepatitis B and/or C co-infected, treatment-experienced HIV patients

enthalten in: HIV clinical trials | 2009

von Pérez-Elías, M. | Gatell, J. | Flores, J. | +7

47

Unboosted atazanavir plus co-formulated lamivudine/abacavir as a ritonavir-sparing simplification strategy in routine clinical practice

enthalten in: HIV clinical trials | 2009

von Santos, J. | Moltó, J. | Llibre, J. | +4

48

Occurrence of selective ritonavir nonadherence and dose-staggering in recipients of boosted HIV-1 protease inhibitor therapy

enthalten in: HIV clinical trials | 2009

von Shuter, J. | Sarlo, J. | Rode, R. | +1

49

Steady-state amprenavir, tenofovir, and emtricitabine pharmacokinetics before and after reducing ritonavir boosting of a fosamprenavir/tenofovir/emtricitabine regimen from 200 mg to 100 mg once daily (TELEX II)

enthalten in: HIV clinical trials | 2009

von Parks, D. | Jennings, H. | Taylor, C. | +2

50

Novel methodology for antiretroviral quantitation in the female genital tract

enthalten in: HIV clinical trials | 2009

von Bennetto-Hood, C. | Johnson, V. | King, J. | +2